195 related articles for article (PubMed ID: 12406909)
21. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
Mizuki M; Schwable J; Steur C; Choudhary C; Agrawal S; Sargin B; Steffen B; Matsumura I; Kanakura Y; Böhmer FD; Müller-Tidow C; Berdel WE; Serve H
Blood; 2003 Apr; 101(8):3164-73. PubMed ID: 12468433
[TBL] [Abstract][Full Text] [Related]
22. C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.
Suh HC; Gooya J; Renn K; Friedman AD; Johnson PF; Keller JR
Blood; 2006 Jun; 107(11):4308-16. PubMed ID: 16469877
[TBL] [Abstract][Full Text] [Related]
23. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
24. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha.
Fukuchi Y; Shibata F; Ito M; Goto-Koshino Y; Sotomaru Y; Ito M; Kitamura T; Nakajima H
EMBO J; 2006 Jul; 25(14):3398-410. PubMed ID: 16858416
[TBL] [Abstract][Full Text] [Related]
26. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment.
Rangatia J; Vangala RK; Treiber N; Zhang P; Radomska H; Tenen DG; Hiddemann W; Behre G
Mol Cell Biol; 2002 Dec; 22(24):8681-94. PubMed ID: 12446786
[TBL] [Abstract][Full Text] [Related]
28. C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo.
Heath V; Suh HC; Holman M; Renn K; Gooya JM; Parkin S; Klarmann KD; Ortiz M; Johnson P; Keller J
Blood; 2004 Sep; 104(6):1639-47. PubMed ID: 15073037
[TBL] [Abstract][Full Text] [Related]
29. CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor.
Wang QF; Friedman AD
Blood; 2002 Apr; 99(8):2776-85. PubMed ID: 11929766
[TBL] [Abstract][Full Text] [Related]
30. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
Shimokawa T; Nunomura S; Fujisawa D; Ra C
Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.
Gombart AF; Hofmann WK; Kawano S; Takeuchi S; Krug U; Kwok SH; Larsen RJ; Asou H; Miller CW; Hoelzer D; Koeffler HP
Blood; 2002 Feb; 99(4):1332-40. PubMed ID: 11830484
[TBL] [Abstract][Full Text] [Related]
33. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
34. Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors.
Dai MS; Heinrich MC; Broxmeyer HE; Lu L
Cytokines Cell Mol Ther; 2000 Mar; 6(1):1-8. PubMed ID: 10976533
[TBL] [Abstract][Full Text] [Related]
35. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
36. C/EBPbeta is required for 'emergency' granulopoiesis.
Hirai H; Zhang P; Dayaram T; Hetherington CJ; Mizuno S; Imanishi J; Akashi K; Tenen DG
Nat Immunol; 2006 Jul; 7(7):732-9. PubMed ID: 16751774
[TBL] [Abstract][Full Text] [Related]
37. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Pulikkan JA; Peramangalam PS; Dengler V; Ho PA; Preudhomme C; Meshinchi S; Christopeit M; Nibourel O; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
Blood; 2010 Dec; 116(25):5638-49. PubMed ID: 20889924
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
Koschmieder S; Halmos B; Levantini E; Tenen DG
J Clin Oncol; 2009 Feb; 27(4):619-28. PubMed ID: 19075268
[TBL] [Abstract][Full Text] [Related]
39. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions.
Reddy VA; Iwama A; Iotzova G; Schulz M; Elsasser A; Vangala RK; Tenen DG; Hiddemann W; Behre G
Blood; 2002 Jul; 100(2):483-90. PubMed ID: 12091339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
